$269.1 Million

SOPHiA GENETICS SA

Initial Public Offering

Bookrunner, July 2021

SOPHiA GENETICS SA

SOPHiA GENETICS SA (“Sophia” or the “Company”) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. The Company’s platform analyzes digital health data and is used in decentralized locations to break down data silos. It also enables healthcare institutions to share knowledge and experiences and build collective intelligence, which allows the Company to serve and partner with all types of institutions in the global life sciences ecosystem, including healthcare providers, centralized laboratories, and pharmaceutical companies.